UnitedHealth Group Incorporated $UNH Shares Acquired by Syverson Strege & Co

Syverson Strege & Co raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 227.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,905 shares of the healthcare conglomerate’s stock after purchasing an additional 2,019 shares during the quarter. Syverson Strege & Co’s holdings in UnitedHealth Group were worth $906,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Caitlin John LLC grew its holdings in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management acquired a new position in UnitedHealth Group in the second quarter valued at approximately $1,324,000. Wealth Effects LLC lifted its stake in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares during the last quarter. Murphy Pohlad Asset Management LLC lifted its holdings in shares of UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after acquiring an additional 791 shares during the last quarter. Finally, Arlington Partners LLC acquired a new position in UnitedHealth Group during the second quarter worth $2,229,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on UNH. Bank of America lifted their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Truist Financial upped their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Oppenheimer cut their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Barclays increased their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Trading Down 1.0%

NYSE:UNH opened at $341.46 on Friday. The stock has a fifty day moving average price of $343.51 and a two-hundred day moving average price of $329.40. The stock has a market capitalization of $309.25 billion, a price-to-earnings ratio of 17.82, a PEG ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $7.15 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.